Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) — Net Asset Momentum
Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) recorded a net asset momentum of 11.9% as of December 2025, with net assets of CN¥1.23 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Beijing Sun Novo Pharmaceutical Research (688621) shareholders funds for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Beijing Sun Novo Pharmaceutical Research Co Ltd Net Asset Momentum (2017–2025)
This chart tracks Beijing Sun Novo Pharmaceutical Research Co Ltd's year-over-year net asset growth across 9 annual reporting periods from 2017 to 2025. The most recent momentum reading is +11.9%, with net assets of CN¥1.23 Billion CNY as of December 2025. For live market cap and overall valuation, see Beijing Sun Novo Pharmaceutical Research stock valuation.
Annual Net Asset History for Beijing Sun Novo Pharmaceutical Research Co Ltd (2017–2025)
The table below shows the complete annual net asset history for Beijing Sun Novo Pharmaceutical Research Co Ltd from 2017 to 2025, covering 9 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check tangible equity quality of Beijing Sun Novo Pharmaceutical Research to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥1.23 Billion | CN¥2.28 Billion | CN¥1.05 Billion | ▲ +11.9% |
| 2024 | CN¥1.10 Billion | CN¥1.99 Billion | CN¥884.65 Million | ▲ +4.3% |
| 2023 | CN¥1.06 Billion | CN¥1.86 Billion | CN¥805.76 Million | ▲ +16.4% |
| 2022 | CN¥908.23 Million | CN¥1.46 Billion | CN¥554.86 Million | ▲ +18.0% |
| 2021 | CN¥769.64 Million | CN¥1.24 Billion | CN¥473.01 Million | ▲ +298.9% |
| 2020 | CN¥192.92 Million | CN¥384.86 Million | CN¥191.94 Million | ▲ +62.4% |
| 2019 | CN¥118.76 Million | CN¥285.51 Million | CN¥166.76 Million | ▲ +60.9% |
| 2018 | CN¥73.82 Million | CN¥201.50 Million | CN¥127.68 Million | ▲ +122.0% |
| 2017 | CN¥33.25 Million | CN¥110.07 Million | CN¥76.82 Million | — |